MTND1P15

Across TCGA pan-cancer cohorts, MTND1P15 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MTND1P15 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MTND1P15 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND1P15 expression acts as an unfavorable survival marker, although some lineages such as KICH and MESO show a favorable association.

UCS, UCEC, and KICH are the cancer types where MTND1P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.244	0.693	<.001	126	view →
UCEC	DFS	Tertile	All	0.513	0.681	.001	78	view →
KICH	DFS	Median	II,III,IV	1.000	0.727	.009	30	view →
THYM	DFS	Tertile	II,III,IV	0.441	0.784	.009	30	view →
COAD	DFS	Tertile	II,III,IV	0.548	0.768	.003	27	view →
HNSC	DFS	Tertile	All	0.460	0.681	.013	27	view →
LUAD	DFS	Tertile	All	0.426	0.681	.004	24	view →
LUSC	DFS	Tertile	III,IV	0.032	0.791	<.001	18	view →
ESCA	DFS	Quartile	All	0.230	0.761	.003	17	view →
MESO	OS	Tertile	III,IV	1.000	0.537	.015	12	view →
DLBC	OS	Quartile	II,III,IV	0.725	1.000	.016	9	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MTND1P15–UCS (OS)

Open the UCS breakdown →